Abstract
Histology and cytology show us the strong heterogeneity of non-Hodgkin’s malignant lymphomas (NHML). Numerous classifications have been proposed. They contain 6–12 classes [18, 25] which more or less match [5, 9, 10, 12, 17, 18, 20, 25]. If, with luck, a nonsophisticated and reproducible classification could predict the evolution, we would have to take it into account and suit the treatment to it. Nevertheless, none of the present classification systems are able to solve the problem for all the patients with NHML. The aim of a practical classification is to clearly distinguish the morphologic groups with the same predictable evolution possibly to cancel those in which the prognosis is still confused. Such well-defined groups have already been described, e.g., African Burkitt’s lymphoma [1], immunoblastic sarcoma [19], convoluted cell lymphosarcoma [18, 30], nodular well-differentiated lymphomas [4, 16], and histiocytosarcoma [22]. Nevertheless, it is still difficult to compare the potential evolution of the morphologic groups from one center to another. There are several causes: the reproducibility is not easy, the treatments are different, and even the frontiers of the disease are badly separated from the chronic lymphocytic leukemia or the acute leukemia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berard, C., O’conor, G. T., Thomas, L. B., Torloni, H.: Histopathological definition of Burkitt’s tumour. Bull. W.H.O.,40, 601 (1969)
Bonnadonna, G., De Lena, M., Lattuada, A., Milani, F., Monfardini, S., Beretta, G.: Combination chemotherapy and radiotherapy in non-Hodgkin’s lymphomata. Brit. J. Cancer, 31 Suppl. 2 481–488 (1975)
Bonnadonna, G., Monfardini. S., De Lena, M., Fossati-Bellani, F., Beretta, G.: Clinical trials with adriamycin. In: International Symposium on Adriamycin, Berlin. Heidelberg. New York: Springer, 1972
Brown, T. C., Peters, M. V., Bergsagel, D. E., Reid, J.: A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Br. J. Cancer, 31 Suppl. II, 174–186 (1975)
Bryon, P. A., Gentilhomme, O., Fiere, D.: Classification histocytologique des lymphomes malins non hodgkiniens. Nouv. Presse med.5, 514–515 (1976)
Byar, D. P.: Analysis of survival data in heterogeneous populations. In: Recent Developments in Statistics, Amsterdam: North Holland, 1977, 51–68
Carbone, P. P., Kaplan, H. S., Musshoff, K., Smither, D. W., Tubiana, M.: Report of the committee on Hodgkin’s disease staging classification. Cancer Res.31,1860–1861 (1971)
Cimo, P., Rudders, R. A., Hensleigh, D.: A clinical trial of adriamycin in the malignant lymphomas. Cancer,34,1571–1575 (1974)
Diebold, J.: Proposition pour classer les hématosarcomes lymphoìdes non hodgkiniens. Ann. Anat. Pathol.,20 35–42(1975)
Dorfmann, R. F.: Classification of non-Hodgkin’s lymphomas. Lancet, 1,1295–1296 (1974)
Ekert, H., Colebatch, J. H., Matthews, R. N.: Short courses of cytosine arabinoside and L- asparaginase in children with acute leukemia. Cancer, 30, 643–647 (1972)
Gerard-Marchant, R. I., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A. G., van Uhnik, J. A. M.: Classification of non-Hodgkin’s lymphomas. Lancet, 2, 406–408 (1974)
Goffinet, D. R., Castellino, R. A., Kim, H., Dorfman, R. F., Fuks, Z., Rosenberg, S. A., Nelsen, T., Kaplan, H. S.: Staging laparotomies in unselected previously untreated patients with non- Hodgkin’s lymphomas. Cancer, 32 672–681 (1973)
Hendin, B., Devivo, D. C, Torack, R., Lell, M. E., Abdelsalam, H. R., Vietti, T. J.: Parenchymatous degeneration of the central nervous system in childhood leukemia. Cancer, 34 468- 482 (1974)
Hustu, H. O., Aur, R. J. A., Verzosa, M. S., Simone, J. V., Pinkel, D.: Prevention of central nervous system leukemia by irradiation. Cancer, 32, 585–597 (1973)
Jones, S. E., Fuks, Z., Bull, M., Kadin, M. E., Dorfman, R. F., Kaplan, H. S., Rosenberg, S. A., Kim, H.: Non-Hodgkin’s lymphomas. IV. Clinico pathologic correlation in 405 cases. Cancer,31,806- 823 (1973)
Lennert, K., Mohri, N., Stein, H., Kaiserling, E.: The histopathology of malignant lymphoma. Br. J. Haematol., 31 Suppl., 72, 193–203 (1975)
Lukes, R. J., Collins, R. D.: New approaches to the classification of the lymphomata. Br. J. Cancer, 31, Suppl. II, 1–28 (1975)
Mathe, G., Belpomme, D., Dantchev, D., Khalil, A., Afifi, A. M., Taleb, N., Pouillart, P., Schwarsenberg, L., Hayat, M., de Vassal, F., Jasmin, C., Misset, J. L., Musset, M.: Immunoblastic lymphosarcomata, a cytological and clinical entity? Biomedicine, 22,473–488 (1975)
Mathe, G., Belpomme, D., Dantchev, D., Pouillart, P.: Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulo sarcomas (Non-Hodgkin’s lymphomas). Biomedicine, 22,177–185 (1975)
Mathe, G., Belpomme, D., Dantchev, D., Pouillart, P., Schlumberger, J. R., Lafleur, M.: Leukaemic lymphosarcomas: respective prognosis of the three types: prolymphocyte, lymphoblastic (or lymphoblastoid) and immunoblastic. Blood Cells, 1, 25–36 (1975)
Mathe, G., Gerard-Marchant, R., Texier, J. L., Schlumberger, J. R., Berumen, L., Paintrand, M.: The two varieties of lymphoid tissue “reticulosarcomas” histiocytic and histioblastic types. Br. J. Cancer,24, 687–695 (1970)
McElwain, T. J., Hardisty, R. M.: Remission induction with cytosine arabinoside and L- asparaginase in acute lymphoblastic leukaemia. Br. Med. J.,4, 596–598 (1969)
Pouillart, P., Ameil, J. L., Mathe, G., Tubiana, M.: Le traitement des lymphorêticulosarcomes de l’adulte (à l’exclusion des formes du carrefour aérodigestif supérieur). Nouv. Presse med., 4, 247–252
Rappaport, H.: Tumors of the haematopoietic system. In: Adas of Tumor Pathology, Section 3, Fascicle 8, Ed.: Washington D.C.. Armed Forces Institute of Pathology, 1966
Rosengerg, S. A.: Report of the committee on the staging of Hodgkin’s disease. Cancer Res.,26,1310 (1966)
Schwartz, D., Flamant, R., Lellouch, J.: L’essai thérapeutique chez l’homme, Paris: Flammarion, 1970
Sotto, J. J., Caillot, P., Sotto, M. F., Lachet, B., Martin, H., Bensa, J. C., Hollard, D.: A cytological classification of non-Hodgkin’s malignant lymphomas based on a statistical analysis. (Submitted for publication in Br. J. Cancer)
Sotto, J. J., Sotto, M. F., Brambilla, E., Martin, H., Michallet, M., Bensa, J. C., Vrousos, C., Hollard, D.: Non-Hodgkin’s lymphoma (NHL): Multifactorial analysis of prognostic factors; special value of the cytology. 16th Intern. Congr. Hematol., Kyoto, 1976
Stein, H., Peterson, N., Gaedicke, G., Lennert, K., Landbeck, G.: Lymphoblastic lymphoma of convoluted or acid phosphatase type—a tumor of T precursor cells. Intern. J. Cancer, 17, 292–295
Tubiana M., Le Bourgeois J. P.: La classification et Ie bilan des bematosarcomes. Bull. Cancer, 61, 39–50 (1974)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Sotto, J.J. et al. (1978). Chemotherapy in Non-Hodgkin’s Malignant Lymphomas According to Potential Evolutive Groups. In: Mathé, G., Seligmann, M., Tubiana, M. (eds) Lymphoid Neoplasias II. Recent Results in Cancer Research, vol 65. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81249-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-81249-1_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81251-4
Online ISBN: 978-3-642-81249-1
eBook Packages: Springer Book Archive